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Abstract
The emergence of microbial antibiotic resistance is a global health threat. In clinical settings,
the key to controlling spread of resistant strains is accurate and rapid detection. As tradi-
tional culture-based methods are time consuming, genetic approaches have recently been
developed for this task. The detection of antibiotic resistance is typically made by measuring
a few known determinants previously identified from genome sequencing, and thus requires
the prior knowledge of its biological mechanisms. To overcome this limitation, we employed
machine learning models to predict resistance to 11 compounds across four classes of anti-
biotics from existing and novel whole genome sequences of 1936 E. coli strains. We consid-
ered a range of methods, and examined population structure, isolation year, gene content,
and polymorphism information as predictors. Gradient boosted decision trees consistently
outperformed alternative models with an average accuracy of 0.91 on held-out data (range
0.81–0.97). While the best models most frequently employed gene content, an average
accuracy score of 0.79 could be obtained using population structure information alone. Sin-
gle nucleotide variation data were less useful, and significantly improved prediction only for
two antibiotics, including ciprofloxacin. These results demonstrate that antibiotic resistance
in E. coli can be accurately predicted from whole genome sequences without a priori knowl-
edge of mechanisms, and that both genomic and epidemiological data can be informative.
This paves way to integrating machine learning approaches into diagnostic tools in the
clinic.
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Author summary
One of the major health threats of 21st century is emergence of antibiotic resistance. To man-
age its human health and economic impact, efforts are made to develop novel diagnostic tools
that rapidly detect resistant strains in clinical settings. In our study, we employed a range of
powerful machine learning tools to predict antibiotic resistance from whole genome sequenc-
ing data for E. coli. We used the presence or absence of genes, population structure and isola-
tion year of isolates as predictors, and could attain average precision of 0.92 and recall of 0.83,
without prior knowledge about the causal mechanisms. These results demonstrate the poten-
tial application of machine learning methods as a diagnostic tool in healthcare settings.
Introduction
Antibiotic resistance has turned into an acute global threat. The rise of bacterial strains resis-
tant to multiple antibiotics is expected to dramatically limit treatment effectiveness [1], leading
to potentially incurable outbreaks. In addition to new drug development efforts, there is an
urgent need for preclinical tools that are capable of effective and rapid detection of resistance
[2, 3], as culture-based laboratory diagnostics test are usually time consuming and costly [3].
To accelerate the diagnosis, genetic tests have been devised to identify known resistance
genes. The increasingly affordable and available whole genome sequencing data from clinical
strains has helped to robustly identify antibiotic resistance determinants, and to curate them
in dedicated databases [4, 5]. Given sequence from a new strain, computational methods can
then look up known causal genes in these resources [5, 6]. Whilst such rule-based models are
highly accurate for some common pathogens with well-characterized resistance mechanisms
(e.g. Mycobacterium tuberculosis and Staphylococcus aureus) [7], they cannot be employed to
detect resistance caused by unknown mechanisms in other major pathogenic strains, and
require regular curation to remain effective.
Prediction approaches based on machine learning have the potential to overcome these
restrictions of rule-based tests. As general-purpose methods, they are agnostic to the causal
mechanisms, and learn useful features directly from data [8–11]. Already, decision tree based
models have proven valuable for predicting resistance and pathogen invasiveness from geno-
mic sequences [12–16]. However, these studies were limited in both the genetic features used
and the methods applied. In particular, both population structure and accessory genome con-
tent could contain predictive information, as resistance determinants may be transferred hori-
zontally from other strains, or inherited vertically from an ancestor [2]. Further, the powerful
deep learning methods that can utilize complex features interactions were not examined.
Here, we systematically evaluate the performance of machine learning algorithms for pre-
dicting antibiotic resistance from E. coli whole genome sequence data. We present genome
sequences and resistance measurements of 255 new isolates and consider them together with
published data from recent large-scale studies, as well as simulated datasets. We test whether
prediction accuracy improves with including temporal data, population structure, and acces-
sory genome content, and assess how a range of population parameters, such as mutation and
recombination rates, influence predictions.
Methods
Isolates
We used 1681 strains from four large-scale clinical and environmental E. coli collections, with
available data on the year of isolation, drug susceptibility phenotypes, and whole genome
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sequence [17, 18]. Furthermore, we collected 255 strains from a range of ecological niches:
hospital sewage and water treatment plant from Sweden (Carl-Fredrik Flach); human clinical
isolates isolated in Pakistan, Syria, Sweden and USA (Culture Collection University of Gothen-
burg); a collection of strains producing extended-spectrum β-lactamases isolated in Sweden
(Christina Åhre´n) and environmental samples from Belgium (Jan Michiels).
Antimicrobial susceptibility testing
Antimicrobials tested for the newly sequenced genomes included beta-lactams (penicillin:
ampicillin (AMP, C.B. (clinical breakpoint): 6μg/ml); cephalosporins: cefuroxime (CXM, C.B.:
8μg/ml), cefotaxime (CTX, C.B.: 4μg/ml), cephalothin (CET, C.B.: 20μg/ml) and ceftazidime
(CTZ, C.B.: 0.25μg/ml)), aminoglycosides (gentamicin (GEN, C.B.: 4μg/ml) and tobramycin
(TBM, C.B.: 8μg/ml)), and fluoroquinolones (ciprofloxacin (CIP, C.B.: 1μg/ml)). Besides these
antibiotics, antimicrobial susceptibility testing results were available for amoxicillin-clavula-
nate (AMC), amoxicillin (AMX) and trimethoprim (TMP) for the previously sequenced
genomes and were used in this study. Antibiotic abbreviations were adopted from the British
Society of Antimicrobial Chemotherapy (www.bsacsurv.org/science/antimicrobials). Concen-
trations used were determined by performing a 2-fold serial dilution, starting from twice the
concentrations listed by the European Committee on Antimicrobial Susceptibility Testing
(EUCAST) on 25/01/2017, until no growth was observed after 16 hours for the common lab
strain BW25113 [19] used as a control in the experiments. In defining resistance, we desig-
nated intermediate strains as resistant.
Sequencing data generation
We extracted DNA with the Bacterial Genomic DNA Isolation 96-Well Kit (Norgen Biotek) as
detailed in the manufacturer’s instructions. Libraries were prepared with standard Illumina
DNA sequencing library preparation protocols, and sequenced on Illumina HiSeq X with 150
bp paired end reads, multiplexing 384 samples per lane, and achieving average depth of cover-
age of 40-fold. We used Kraken, which accurately assigns taxonomic labels to the short DNA
reads [20], to confirm the presence of E. coli reads in the pool. The raw sequences for the
sequenced data in this study have been deposited in the European Nucleotide Archive (ENA)
under the accession numbers described in S1 Table.
Pan-genome determination
Paired-end reads for the isolates sequenced both here and previously were assembled with Vel-
vet [21] and put through an improvement pipeline [22]. In order to reconstruct the pan-
genome, we used the output assemblies and annotated these with Prokka [23]. The annotated
assemblies produced by Prokka were then used as input for Roary [24] to build the pan-
genomes with the identity cut-off of 95%. In the process of pan-genome construction, coding
regions were extracted from the annotated assemblies and then converted to protein sequences
(partial coding sequences were filtered out). Roary yielded clusters of homologous gene groups
and produced a matrix for the presence and absence of ortholog accessory genes. The variant
sites (SNPs) in the core genome alignment were extracted with a SNP sites tool (www.github.
com/sanger-pathogens/snp-sites). To visualize the phylogenetic tree with the associated meta-
data, we used iTOL [25]. The pan-genome data, including sequences of the gene ortholog fam-
ilies, as well as the annotated assemblies for strains are provided in Github (www.github.com/
DaneshMoradigaravand/PanPred).
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Population structure calculation
We mapped the short reads to the reference EC958 genome sequence [26] as detailed in [27],
and calculated the pairwise SNP distance (number of differing sites) for the core genome align-
ment of strains with functions in the ape package in R [28]. We identified clusters within the
population using a distance-based method in the adegenet package [29]. We clustered
sequences using the sequence distance metric with the adegenet package for all possible num-
ber of clusters from 1 to number of strains. To this end, we employed the gengraph function in
the package that produces graphs from genetic distances, in which pairs of strains are con-
nected if their genetic distance is less than a given cut-off. We considered each connected com-
ponent of the obtained graph as a cluster. Based on these clusterings, we constructed the
population structure matrix S, where sij = k if strain i belongs to cluster k in the clustering with
at most j clusters.
Simulated datasets
To evaluate the performance of prediction tools, we simulated pan-genomes with the simula-
tion script in the Scoary package [30] (https://github.com/AdmiralenOla/Simulate_pan_
genome). The simulation process begins with a single genome with 3000 core and 6000 acces-
sory genes that undergoes duplication and gene loss/gain in every generation, and continues
until a desired number of genomes is reached; we tested population sizes of 130, 260, 650 and
1300. We examined penetrances, defined as the probability of acquisition/loss of the resistance
phenotype simultaneously to the acquisition/loss of the causal resistance gene, of 0.5, 0.6, 0.7,
0.8, 0.9 and 1.
Feature calculation
We examined different predictors as inputs: 1) matrix of the presence-absence of accessory
genomes within the pan-genome (G), where gij is 1 if gene i is present in strain j, and 0 other-
wise; 2) matrix of population structure inferred from core-genome (S) defined above, and one-
hot encoded 3) matrix of SNP sites (SNP), where SNPij = 0 if strain j carries the consensus
allele at site i, and 1, 2, 3, 4, 5 if it contained A, T, C, G nucleotide or missing information,
respectively; 5) matrix of indels (indel), where indelij = 0 if strain j has the reference sequence
at site i and 1 if it contained any indel and 6) matrix of years of isolation (Y). We standardized
each feature to have 0 mean and unit variance. Genes, strain clusters, and SNPs with identical
indicator pattern were collapsed, so there are no duplicate rows in the G, S, SNP matrices.
Resistance prediction
We performed prediction using various combinations of input matrices using resistance indi-
cator as the output. We employed 80% of the data for training and tuning the various models,
using 4-fold cross-validation to select the best parameters for each model class according to
mean accuracy. The performance of the selected model was then assessed on the remaining
20% held-out data. Positive and negative corresponded to the resistant label.
Four different models were used along with a rule-based baseline
Logistic regression with L2 regularization. We employed the “LogisticRegression” function in
the Scikit-learn python package (www.scikit-learn.org) [31], with the “lbfgs” solver, and varied
the regularization parameter strength from 0 to 1 with step size 0.01.
Random forest classifier. We employed the “RandomForestClassifier” function in Scikit-
learn. We varied key parameters including the number of trees in the forest (n_estimators;
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100, 600, 2000, 5000) and number of features considered for splitting at each leaf node (max_-
features), i.e. when searching for the best split, we used total number, as well as square root
and binary logarithm selection of the number of features. We also changed parameters con-
trolling the size of tree, including values for minimum number of samples required at a leaf
node (min_samples_leaf) (values: 1,5), minimum number of samples required to split an inter-
nal node (min_samples_split) (values: 2, 3). We also changed the maximum depth (max_-
depth) of the tree by assuming that nodes are expanded until all leaves are pure or until all
leaves contain less than 10 and 50 strains. We used bootstrap samples for building trees, out-
of-bag samples to estimate accuracy, and Gini impurity as the criterion for the information
gain.
Gradient boosted decision trees. We used the “GradientBoostingClassifier” implementa-
tion in Scikit-learn, with learning rate 0.1, and 300, 600 and 5000 boosting stages, and deviance
loss. We aimed to make the parameters considered for random forests and gradient boosted
decision trees as similar as possible. Therefore, we used the hyperparameter values for the deci-
sion tree parameters shared with random forests, including max_features, min_sample_leaf
and mean_samples_split. In order to assess the robustness of feature importance analysis, we
repeated the optimization with 50 random seeds. To account for overfitting, we also ran itera-
tions with a fraction of 0.8 of samples for fitting the individual base learner models. This
turned the model into a stochastic gradient boosting model. As a measure for feature impor-
tance, we counted the number of times a feature used in optimization, as well as the average
feature rank and importance across multiple replicates.
Deep neural networks. We employed the keras library in python (www.keras.io) to build
fully connected deep neural networks. We tested various network topologies, including two,
four and six layer networks, with two output nodes corresponding to resistant and susceptible
states, and 100 and 150 nodes in each internal layer and 200, 400 and 600 nodes for the first
layer. We used Adam to train for 20 epochs, with batch size of 128, learning rate of 0.1, drop-
out of 0 and 0.2, and stopping when the validation set performance decreased. Due to the
small training dataset size compared to the number of features, for ~50% of runs the loss in the
validation did not decrease by the end of training the network. We randomly partitioned the
data into training (56%), validation (14%) and test (30%) sets, and trained models with differ-
ent parameters on the training set, evaluated quality on the validation set, and final perfor-
mance on the test set.
Rule-based baseline. We compared our results with a rule-based method based on the
detection of known resistance genes. To this end, we employed srst2 [32] and mapped
short reads to the ResFinder and the Comprehensive Antibiotic Resistance Database
(CARD) of known resistance genes in the srst2 package, using the cut-off of 60% for the
length coverage. We checked the ESBL and inhibitor-resistance status (for AMC resis-
tance) of beta-lactamases according to the Lahey hospital and medical center database
(www.lahey.org/Studies) and CARD. For aminoglycosides, variants of genes encoding
aminoglycosides modifying enzymes were considered as resistance. For trimethoprim,
variants of dihydrofolate reductase genes were assumed to cause resistance. Finally, for
ciprofloxacin, the qep and oqx genes, belonging to major facilitator superfamily transport-
ers, were considered as resistance genes.
Details of the performance of each hyperparameter set, as well as distribution of known
resistance genes (from CARD and Resfinder), are provided in the Github directory (www.
github.com/DaneshMoradigaravand/PanPred). Prediction results for the best performing
model are detailed in S3 Table.
Prediction of antibiotic resistance from pan-genome data
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Results
Our data comprise 1936 samples that have been full genome sequenced, and phenotyped for
resistance of 11 antibiotics. Resistance was distributed both within specific clades as well as
emerging sporadically on divergent lineages (S1 Fig), with an average frequency of 0.35 per
drug (range: 0.15–0.63). This pattern suggests both vertical and horizontal spread of resistance
determinants. Genome sequences were processed to give gene and polymorphism presence
information (1,390 core genes present in >99% of lineages, 90,261 genes present in more than
one lineage, 1,432,145 variable sites in core genes), and 1,071 population structure features.
We used these input features to test the ability of four machine learning models—logistic
regression, random forests, gradient boosted decision trees, and deep neural networks—to
predict antibiotic resistance. We varied model hyperparameters, as well as input data types, to
establish the most accurate models within each class (Methods). Results were similar on the
training and test datasets, demonstrating lack of bias in their choice (S2 Fig). Gradient boosted
decision trees performed best for predicting resistance of 11/11, and susceptibility of 9/11
drugs (Fig 1), with average precision of 0.93 and recall of 0.83 (S3 Fig, Table 1). Perhaps sur-
prisingly, deep learning models that account for complex non-linear relations amongst fea-
tures did not provide substantial improvement over the simpler logistic regression models, or
random forests (Fig 1).
Knowledge of what features that aid prediction will help prioritize data collection and diag-
nostic efforts. The gene presence and absence predictor (G) was used in all the best predictive
models for each of the considered methods (Fig 1; lower panel). This is not surprising, given
multiple known resistance mechanisms driven by accessory gene content, e.g. for beta-lactams
and aminoglycosides. Population structure information (S) and year of isolation data (Y) were
also used in 11 and 30 out of 44 best models, respectively. Adding gene presence to population
structure features, with or without the year of isolation, improved the accuracy score by 0.12
on average (S4 Fig). In contrast, once gene presence had been accounted for, there was limited
performance gain when including population structure features (S3 Fig). This suggests that
accessory gene content already contains information about population structure, which
reflects the pattern of polymorphisms in the core genome. Indeed, core genome distance and
accessory gene difference matrices are not independent (p< 0.01, Mantel test), which is likely
explained by accessory genes acquired by clade ancestors, followed by limited turnover.
Next, we asked which individual features are most frequently utilized. We measured feature
importance as the number of times it was used for gradient boosted decision trees, the best
performing method, across 50 random fitting replicates on fixed training date (S5 Fig). In gen-
eral, known resistance genes were identified as the most important, and were most frequently
used features for predicting resistance to beta-lactams and aminoglycosides, e.g. ESBLS,
including variants of blaTEM-1 and blaCTX-M-15, and extra copies of ampC and phnP efflux
pump genes (S2 Table). For example, the known beta-lactamase bla-CTX-M gene ranked first
in all models for predicting resistance to beta-lactam ceftazidime, which followed by some
genes with unknown function and ampC (S5A Fig). Further to known genes, genes that are
tightly linked to causal resistance genes may be identified as important. The group_17190
gene, highly ranked for cefuroxime and cefotaxime was linked to blaCTX-M-15 (S2 Table).
For 10 out 11 drugs the year of isolation was used in the best performing model. However
this feature did not improve accuracy when added to the structure and genetic features for
nearly all drugs expect ampicillin and to lesser extend cephalothin (S4A Fig). This was indi-
cated by the temporal distribution of the data, where all the strains collected in 2015 were resis-
tant to these antibiotics. These findings demonstrate that although known resistance genes
were most predictive, other features, i.e. year of isolation, may be reproducibly utilized for
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prediction as well (S5B Fig). Nevertheless, it is clear that the inclusion of some features, such as
collection year, reflects bias in the training data rather than biological importance. Time of iso-
lation is informative when an outbreak of multi-drug resistant strain occurs at a limited time
period. While not mechanistically informed, time of isolation, and perhaps other clinical and
epidemiological features may be integrated and utilized if they robustly improve performance.
Population structure information was less often selected than gene presence and absence
and year of isolation in the best performing models (Fig 1). Nevertheless, training only on pop-
ulation structure produced an average accuracy of 0.79 (range: 0.65–0.91), and this perfor-
mance could not be achieved with randomized phenotypes (S6 Fig). Population structure
features capture both recently diverged and deep clades (Fig 2A), and features included in the
models were not limited to a single lineage or common depth (e.g. Fig 2B). As an example,
CL129 distinguishes clusters by positing a maximum pairwise sequence distance of 129 nucle-
otides between isolates, and was identified as the most important feature. Cluster membership
Fig 1. Prediction performance of the best tuned models. Accuracy and F1 score (harmonic mean of precision and recall; y-axis) for resistant (top panel) and
susceptible (middle panel) phenotypes for four predictive models (red: gradient boosted decision trees; green: logistic regression; teal: random forests; purple: deep
learning) across eleven antibiotics (x-axis). The best model of each class for every drug (x-axis) was identified based on the accuracy for predicting resistance and
employed a number of possible combinations of gene presence, population structure, and year of isolation (lower panel; black: feature used; white: feature not used).
https://doi.org/10.1371/journal.pcbi.1006258.g001
Prediction of antibiotic resistance from pan-genome data
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1006258 December 14, 2018 7 / 17
at this level of similarity informs of resistance, as 73% of clusters with at least two strains con-
tained either only resistant or only susceptible strains (Fig 2C). In these cases, resistance status
of an ancestral strain of the clades was likely retained in descendants and did not change due
to horizontal gene transfer, mutation, or sporadic gene loss. Altogether, the results show that
predictive models can utilize genetic relatedness and population structure for predicting resis-
tance, as has been observed in traditional eukaryotic genetics [9].
Due to the correlation between the pan-genome and structure data, determining the rela-
tive contribution of gene content to prediction is not straightforward (see Discussion). In
order to obtain insights into this, we assessed the performance of the model on a new lineage.
To this end, we used the ST131 lineage as test dataset, and the rest of the data for training, and
compared performance of gene, population structure, and combined models to random selec-
tion of equally-sized test data (S7 Fig). For drugs with a known causative resistance gene, (i.e.
every drug except CIP), adding gene information increases prediction accuracy by an average
0.24. The improvement is more pronounced if the resistance accessory gene has high pene-
trance and arises independently across different lineages (e.g. the trimethoprim resistance
caused by the dfrA genes). No accessory gene is responsible for ciprofloxacin resistance and
ST131 is highly resistant to ciprofloxacin. As a result, models with accessory gene and structure
inputs perform equally well. Further, it is worth noting that the control accuracy (where held-
out isolates were randomly sampled) was on average 0.28 higher for all drugs excluding AMP,
AMX and CET, mainly due to higher sensitivity (S7 Fig). For these remaining antibiotics, the
performance on the held-out clade was as good as for control. This is likely explained by more
than 90% of the clade strains being resistant, and any clade correlate, either accessory gene
presence, or population structure indicator, enabling accurate prediction. Overall, the results
show that the accessory gene content may be used both for its genetic content of causative
resistance determinants, and a proxy for structure, although the performance can worsen on
novel lineages.
While the major mechanism for evolving antibiotic resistance is gene acquisition, muta-
tions and indels on chromosomes may also play a role, and therefore aid prediction. We thus
next included single nucleotide polymorphism (SNP) and indel data for gradient boosted deci-
sion trees and re-fitted the model. Predictive performance improved for 8 of the 11 antibiotics,
and significantly so for cefuroxime and ciprofloxacin (S4B Fig). As anticipated, the largest
accuracy improvement of 2.8% (C.I.: 1.61%-3.85%) occurred for ciprofloxacin, resistance
Table 1. Prediction metrics on held out data for the best performing gradient boosted decision trees model.
Antibiotic TN FP FN TP S.PRC S.RCL R.PRC R.RCL S.FSc R.FSc ACC
AMP 24 5 5 118 0.83 0.96 0.83 0.96 0.83 0.96 0.93
AMX 80 8 15 115 0.84 0.93 0.91 0.89 0.87 0.91 0.89
AMC 221 34 29 52 0.89 0.60 0.87 0.64 0.87 0.62 0.81
CTZ 309 4 13 50 0.96 0.92 0.99 0.80 0.97 0.85 0.95
CTX 281 5 6 66 0.98 0.93 0.98 0.922 0.98 0.92 0.97
CXM 273 11 24 68 0.92 0.86 0.96 0.74 0.94 0.79 0.91
CET 38 12 17 85 0.70 0.88 0.76 0.83 0.72 0.85 0.81
GEN 316 1 11 48 0.97 0.98 0.99 0.81 0.98 0.89 0.97
TBM 104 3 7 38 0.94 0.92 0.98 0.84 0.95 0.89 0.93
TMP 73 7 10 62 0.88 0.90 0.91 0.86 0.90 0.88 0.89
CIP 281 10 16 69 0.95 0.87 0.97 0.81 0.95 0.84 0.93
TN: true negatives, FN: false negatives, FP: false positives, TP: true positives, PRC: precision, RCL: recall, S: susceptibility, R: resistance, ACC: accuracy for resistance.
https://doi.org/10.1371/journal.pcbi.1006258.t001
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against which is known to involve chromosomal mutations [33, 34]. Accordingly, the three
most important identified features were variants in chromosomal quinolone-resistance-deter-
mining regions of the genes encoding DNA gyrase (gyrA), and topoisomerase IV parC. For
other antibiotics, the addition of SNP data either did not greatly improve or worsened predic-
tion performance (S4B Fig, Discussion). The addition of indel information did not signifi-
cantly improve prediction, perhaps due to low frequency of such mechanisms.
A possible limitation for applying machine learning methods to detect antibiotic resistance
is the unavoidably small number of samples (1,936 in this study) compared to the number of
features (~18,270 in this study after collapsing the fully correlated features). To better under-
stand how this imbalance impacts performance, we simulated data from different sample sizes
using a range of penetrances for a single resistance determinant. As anticipated, the
Fig 2. Population structure and phenotypic distribution of the input data. A) Phylogenetic distribution of clusters identified in the population for SNP distance cut-
off values of 2, 143, 5054 and 14489 (outer circles) relative to the phylogenetic tree. B) Phylogenetic distribution of correct calls (true positives, true negatives) and errors
(false positives, false negatives) when predicting cephalothin (CIP) resistance with the best performing gradient boosted model. The accuracy for resistance was 0.91. C)
Phylogenetic distribution of the most important identified population structure feature, clustering with SNP cut-off of 129 (outer ring), compared with the phylogenetic
distribution of resistance phenotype (inner ring; blue: susceptible; light red: intermediate and red: resistant) on the test dataset. Clusters with more than one member are
shown.
https://doi.org/10.1371/journal.pcbi.1006258.g002
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performance of gradient boosted decision trees dropped when the penetrance of the resistance
determinant decreased (S8 Fig). However, there was no reduction in prediction and recall for
resistance upon decreasing the population size, even when using only 130 strains. Overall,
these findings suggest that the large number of features relative to sample size does not impact
model performance for high frequency causal genes.
The current methods employ rule-based models to predict resistance from a small number
of known determinants. We used srst2 [32] to identify known resistance genes for cephalospo-
rins, penicillins, aminoglycosides, trimethoprim and ciprofloxacin, and used this to compare
the performance of our models with the prediction based on the presence of known genes in
two databases. Except for amoxicillin, machine learning models attained a higher accuracy for
prediction that rule-based approaches (S9 Fig). This is mainly due to reducing false negatives
for resistance, where no known resistance gene was detected in the resistant strains.
Finally, we utilized the information from rule-based methods to better understand predic-
tion errors for our model (Table 2). There were up to 47 false positive resistance calls across
different antibiotics for strains that carried known resistance genes (beta-lactams, aminoglyco-
side modifying enzymes and dfr genes from CARD and Resfinder databases), but were anno-
tated as susceptible. Manual inspection confirmed that all of these genes were fully covered by
sequence data, and almost identical to the known resistance genes. In a similar vein, up to 17
false negative resistance calls did not contain a known causal determinant according to the
same databases. Further, up to 65 resistant strains were correctly marked as resistant by our
model, but contained no known resistance gene (Table 2). These discrepancies may be
explained by unknown mechanisms for resistance, phenotypic resistance testing error, or
genomic sequence coverage. As neither approach was perfect, predictive models in combina-
tion with rule-based methods may help identify cases that require further analysis or repeating
the susceptibility tests, ultimately leading to improved diagnostics and novel mechanisms.
Moreover, the discrepancy between rule-based and machine learning methods is most pro-
nounced for CIP and AMC resistance. This is not surprising, as the resistance gene for CIP
determine relatively small increases in the MICs of quinolones and are not considered in resis-
tance screening [35]. Despite genome sequence information not being complete for any of the
strains, our best performing model attained an accuracy of 0.93. This was achieved due to the
use of genetic information correlated with resistance genes. For AMC resistance, bla-TEM
Table 2. Comparison of prediction results with a rule-based models with Resfinder and CARD database of antibiotic resistance genes.
Antibiotic Acc.
ML
Acc.
CARD
Acc.
ResFinder
TP w/o Res.
gene (CARD)
FN w/o Res.
gene (CARD)
FP w Res. gene
(CARD)
TP w/o Res. gene
(ResFinder)
FN w/o Res. gene
(ResFinder)
FP w Res. gene
(ResFinder)
AMP 0.93 0.88 0.72 1/118 1/5 3/5 25/118 3/5 2/5
AMX 0.89 0.85 0.69 2/116 8/14 7/9 12/116 3/14 5/9
AMC 0.81 0.6 0.73 16/49 16/32 15/31 48/49 31/32 1/31
CTZ 0.95 0.8 0.65 0/49 2/14 1/4 10/49 5/14 4/4
CTX 0.97 0.8 0.64 0/67 0/5 1/2 9/67 3/5 1/2
CXM 0.91 0.8 0.67 0/67 8/25 4/7 15/67 13/25 5/7
CET 0.81 0.71 0.67 4/85 9/17 6/11 24/85 8/17 5/11
GEN 0.97 0.64 0.63 0/48 4/11 1/1 1/48 4/11 1/1
TBM 0.93 0.64 0.62 0/38 1/7 3/3 0/38 1/7 3/3
TMP 0.89 0.74 0.86 9/62 8/10 3/5 4/62 2/10 5/5
CIP 0.93 0.76 0.75 63/68 17/17 3/9 65/68 17/17 0/9
True positives (TP), false positives (FP) and false negatives (FN) from Table 1.
https://doi.org/10.1371/journal.pcbi.1006258.t002
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gene was the most important feature used in prediction. However, not all variants of bla-TEM
are known to exhibit inhibitor resistance [36]. In this case, prediction based on the presence of
this gene may result in discrepant results with observed phenotypes. There results demonstrate
that when genetic information on a key resistance gene is missing or incomplete in some resis-
tant strains, the use of correlated genetic information leads to a reduction in false negatives for
resistance, and improves accuracy.
Discussion
We examined the ability of four different machine learning methods to predict antibiotic resis-
tance from pan-genome data in E.coli, without making assumptions about the underlying
genetic mechanisms. Our tests revealed that accessory genome data is needed for high accu-
racy in general, but that population structure information alone also allows prediction well
above chance. This is particularly helpful when the genetic relatedness is known from a novel
strain, whilst the underlying genetic resistance mechanism is unknown or less well-known,
such as tend to be the case for recently introduced antibiotics. The quantification of the contri-
bution of the population structure features remains out of the scope of this study.
Our input dataset was diverse. The collection comprised seven sequence types and strains
from 15 consecutive years across a range of geographical locations. The majority of isolates
(1509 of 1936 samples) were from a nationwide study across hospitals in the United Kingdom
and Ireland [17], and associated with bacteremia. This geographical bias is not expected to
affect the performance of the model on a new clinical dataset, since E. coli sequence types (e.g.
ST131 clone [37]) are circulated across hospitals worldwide. However, as isolates from poten-
tial reservoirs, including hospital sewage and wastewater treatment plants, were underrepre-
sented in training data (99 of 1936 samples), we cannot conclusively assess how well the
trained models detect resistance in samples from these sources. More data are needed to
develop robust models across the entire species range, especially if resistance mechanisms dif-
fer in the various niches.
The phenotype data was binary—each isolate was deemed either resistant or not to a com-
pound. It is clear that this is an oversimplification of reality, as substantial variation hides
within both categories. As evolutionary pressure is applied to the resistant population through
the use of antibiotics, it will influence how quickly it spreads within and between patients, as
well as in bacterial populations at large. To predict treatment outcomes, correctly design inter-
ventions and allocate societal resources, it will therefore be important to be able to accurately
predict resistance quantitatively as well. This requires non-binary resistance data, acquired at
high accuracy and throughput.
We compared five models, including a rule-based standard. As a baseline machine learning
approach, we employed logistic regression, and contrasted it against arguably the most useful
current methods. Indeed, deep neural networks, random forests, and gradient boosting form
the top three most frequent winners in Kaggle (the world’s largest community of data scientists
and machine learners) competitions (https://www.kaggle.com/antgoldbloom/what-
algorithms-are-most-successful-on-kaggle). In this regard, our findings confirm the utility of
ensemble methods, and in particular boosting models, for predicting antibiotic resistance.
While deep learning models are able to capture higher order interactions between features,
and therefore often outperform simpler alternatives [38], they did not provide additional
advantage here. Tree-based methods are often used as an intermediate between simple models
that treat features independently, like logistic regression, and more complex, but poorly inter-
pretable models. Indeed, random forest readouts can be analysed for feature importance as we
have done here, and even detecting genetic interactions (e.g. [39]).
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While the most frequently used features often captured information about known resis-
tance genes, we do not attempt to interpret the identified links as causal. As for association
methods [30, 40], the true impact of genetic features is confounded by their phylogenetic dis-
tribution and population structure. Therefore, approaches to distinguish causal resistance
genes from all correlated markers require additional experimental study.
Recent reports have confirmed the strength of tree-based methods for predicting clinical
attributes. For example, Wheeler et al. used random forests to predict invasiveness of Salmo-
nella enterica lineages [16]. In another study, a tree ensemble was trained with boosting to pre-
dict the minimum inhibitory concentration from DNA k-mers for a large-scale Klebsiella
pneumoniae panel [12], but the value of using core genome compared to accessory genes was
not investigated. A very recent study [11] employed a different set of machine learning meth-
ods to predict resistance phenotype from pan-genome data but this study was conducted a
small data set without testing gradient boosting and neural networks.
Including variant data or k-mers in the model greatly increases the number of features.
However, adding the ~1 million additional single nucleotide features to ~20,000 others did not
improve the results for most drugs in our dataset. This suggests that for E. coli collections or
similar Enterobacteriaceae, in which resistance is driven to a great extent by horizontal transfer
of entire genes, only pan-genome data may be directly useful in early screenings for resistance,
and including nucleotide-level information may become more beneficial in the future, once
causality is established for a broader range of genes, SNPs and indels. Furthermore, we expect
methods that take population structure features as input to perform better in clonal organisms
like E. coli compared with more recombinogenic species. The relative contributions of SNPs
and population structure features to prediction will likely vary when methods are applied to
different pathogens.
What is keeping predictive models from reaching 100% accuracy? One of the reasons for
limited improvement due to SNP data could be their high false negative rate. Our model will
fail to identify SNPs in regions that are too large for SNP detection, or SNPs that do not occur
in the core genome, i.e. in the accessory genome. Furthermore, several non-genetic causes may
influence predictive ability. The genome-based prediction cannot account for various non-
genomic resistance mechanisms, such as resistance due to biofilm formation, or alteration of
methylation patterns. Consequently, future studies should assess the value of even broader
data for accurate prediction, ranging from transcriptome and proteome to other clinical and
epidemiological data, such as cross-resistance and history of antibiotic therapy. Integrating
these information sources from large isolate panels into a single predictive framework will lead
to a rational basis for introducing machine learning in decision-making in public health.
Supporting information
S1 Fig. Phylogenetic distribution of resistance and Sequence Types (ST)s across the phylo-
genetic tree. A) A neighbor-joining phylogenetic tree from SNPs with associated resistance
and susceptibility, major STs, and year of isolation information. B) Number of resistant (dark
red), intermediate (light red) and susceptible (blue) strains (y-axis) for each of the 11 consid-
ered antibiotics (x-axis).
(TIF)
S2 Fig. Comparison of the accuracy of prediction on the training dataset and the held-out
data set. Bars with dark colors show the mean accuracy for the tuned model with 4-fold cross
validation on the training dataset. The error bars are standard deviations. Bars with light colors
are the accuracy of the tuned model on the held-out (test) dataset.
(TIF)
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S3 Fig. Prediction performance of the best tuned models. The precision (panels 3,4) and
recall (panels 1, 2) for resistance and susceptibility for the best tuned predictive models on
held out data for four predictive models (red: gradient boosted random forests; green: logistic
regression; teal: random forests; purple: deep learning) across eleven antibiotics (x-axis). The
best model, i.e. model with highest accuracy for resistance, of each class for every drug (x-axis)
employed a number of possible combinations of gene presence, population structure, and year
of isolation (lower panel; black: feature used; white: feature not used).
(TIF)
S4 Fig. Improvement in the prediction performance. This was measured as increase or
decrease in accuracy scores for resistance, after the inclusion of A) gene presence-absence (G)
and population structure (S) input data and year of isolation (Y). B) SNP and indel data. Each
bar shows the difference (extended feature set performance minus original feature set perfor-
mance) between the mean accuracy scores for best performing models on the training data,
with 4-fold cross validation. The error bars show the harmonic mean of standard deviation val-
ues for the two compared conditions, as defined in S3 Fig.
(TIF)
S5 Fig. Feature importance analysis for the gradient boosted decision trees results. A)
Average ranking (y-axis) and average importance (x-axis) of each feature across 50 random
restarts of training for each feature (markers; size proportional to the frequency of feature utili-
zation) for ceftazidime (CTZ). Annotations for top genes is shown in the figure. A full list of
the genes is provided in S2 Table. B) Frequency (y-axis) of the year (green), population struc-
ture (blue) and gene presence (red) features for 100 most important features (x-axis) in the 11
antibiotics (panels) across the 50 random training restarts. The best performing model inputs,
shown in Fig 1, are denoted to the right of each plot.
(TIF)
S6 Fig. Prediction information of population structure data. Accuracy score for prediction
of antibiotic resistance from population structure alone (y-axis) for randomized labels (violin
plots) and real data (red marker) across 11 antibiotics (x-axis). The violin plots aggregate
results from 100 bootstrap replicates of randomly sampled phenotype labels. A gradient
boosted decision trees model with 600 iterations was used as predictive model.
(TIF)
S7 Fig. Assessment of the performance of model with different features on a new lineage
for 11 drugs. We left out ST131 strains as test data set and trained the model on the rest of
strains (w/o ST131). Results are compared with a control case, in which test and train datasets
with the same size as w/o ST131 were created by a random selection (Control). Models were
tuned with three features combinations, i.e. S (population structure), G (Accessory genes) and
G+S (Accessory genes and population structure). The first row shows frequency of resistant
strains in the train and test datasets for the two cases. The second panel shows the accuracy for
predicting resistance and the difference between the accuracy values, i.e. Accuracycontrol-
Accuracyw/o ST131. The two last panels show precision and recall for resistance with three fea-
ture combinations.
(TIF)
S8 Fig. Effect of sample size on the performance of the predictive model. Precision (left
panel) and recall (right panel) for resistance phenotype for different population sizes (colors)
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and penetrances (x-axis) in simulated pan-genome data using gradient boosted decision trees.
(TIF)
S9 Fig. Comparison between rule based and machine learning methods. Results from Rule
based methods with two databases of known resistance genes, i.e. ResFinder and CARD, were
compared with results from the best performing models from our study for 11 drugs. We eval-
uated the performance on the held-out dataset used in assessing predictive models.
(TIF)
S1 Table. List of isolates with associated metadata and accession numbers in the European
Nucleotide Archive (ENA).
(CSV)
S2 Table. List of important accessory genes and their functions for feature importance
analysis with the best performing gradient boosted decision trees models shown in S4 Fig.
The importance metrics include the number of runs (total 50 runs), in which the feature was
used during model optimization and the average ranking and importance for the feature in
these runs. Sequences for the genes are provided in the Github directory (see Methods).
(CSV)
S3 Table. Prediction results for the best performing model for 11 drugs.
(CSV)
Acknowledgments
Christina Åhre´n, Nahid Karami, Carl-Fredrik Flach, Ed Moore (Culture Collection University
of Gothenburg, CCUG), Jan Michiels and Marco Galardini are gratefully acknowledged for
providing strains. Daniel Jae´n Luchoro, Fabrice E. Graf, Owens Uwangue and Viktor Garellick
are gratefully acknowledged for technical assistance and helpful discussions.
Author Contributions
Conceptualization: Danesh Moradigaravand.
Data curation: Danesh Moradigaravand.
Formal analysis: Danesh Moradigaravand.
Funding acquisition: Leopold Parts.
Investigation: Danesh Moradigaravand.
Methodology: Danesh Moradigaravand.
Project administration: Leopold Parts.
Resources: Danesh Moradigaravand, Martin Palm, Anne Farewell.
Supervision: Ville Mustonen, Jonas Warringer, Leopold Parts.
Validation: Danesh Moradigaravand.
Visualization: Danesh Moradigaravand.
Writing – original draft: Danesh Moradigaravand, Leopold Parts.
Writing – review & editing: Danesh Moradigaravand, Martin Palm, Anne Farewell, Ville
Mustonen, Jonas Warringer, Leopold Parts.
Prediction of antibiotic resistance from pan-genome data
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1006258 December 14, 2018 14 / 17
References
1. Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. Understanding the mech-
anisms and drivers of antimicrobial resistance. Lancet. 2016; 387(10014):176–87. Epub 2015/11/26.
https://doi.org/10.1016/S0140-6736(15)00473-0 PMID: 26603922.
2. Sommer MOA, Munck C, Toft-Kehler RV, Andersson DI. Prediction of antibiotic resistance: time for a
new preclinical paradigm? Nat Rev Microbiol. 2017; 15(11):689–96. Epub 2017/08/02. https://doi.org/
10.1038/nrmicro.2017.75 PMID: 28757648.
3. Burnham CD, Leeds J, Nordmann P, O’Grady J, Patel J. Diagnosing antimicrobial resistance. Nat Rev
Microbiol. 2017; 15(11):697–703. Epub 2017/10/13. https://doi.org/10.1038/nrmicro.2017.103 PMID:
29021600.
4. McArthur AG, Waglechner N, Nizam F, Yan A, Azad MA, Baylay AJ, et al. The comprehensive antibiotic
resistance database. Antimicrob Agents Chemother. 2013; 57(7):3348–57. Epub 2013/05/08. https://
doi.org/10.1128/AAC.00419-13 PMID: 23650175; PubMed Central PMCID: PMCPMC3697360.
5. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of
acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012; 67(11):2640–4. https://doi.org/
10.1093/jac/dks261 PMID: 22782487; PubMed Central PMCID: PMCPMC3468078.
6. Stoesser N, Batty EM, Eyre DW, Morgan M, Wyllie DH, Del Ojo Elias C, et al. Predicting antimicrobial
susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence
data. J Antimicrob Chemother. 2013; 68(10):2234–44. Epub 2013/06/01. https://doi.org/10.1093/jac/
dkt180 PMID: 23722448; PubMed Central PMCID: PMCPMC3772739.
7. Bradley P, Gordon NC, Walker TM, Dunn L, Heys S, Huang B, et al. Rapid antibiotic-resistance predic-
tions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis. Nat
Commun. 2015; 6:10063. Epub 2015/12/22. https://doi.org/10.1038/ncomms10063 PMID: 26686880;
PubMed Central PMCID: PMCPMC4703848.
8. Martens K, Hallin J, Warringer J, Liti G, Parts L. Predicting quantitative traits from genome and phe-
nome with near perfect accuracy. Nat Commun. 2016; 7:11512. Epub 2016/05/11. https://doi.org/10.
1038/ncomms11512 PMID: 27160605; PubMed Central PMCID: PMCPMC4866306.
9. Hallin J, Martens K, Young AI, Zackrisson M, Salinas F, Parts L, et al. Powerful decomposition of com-
plex traits in a diploid model. Nat Commun. 2016; 7:13311. Epub 2016/11/03. https://doi.org/10.1038/
ncomms13311 PMID: 27804950; PubMed Central PMCID: PMCPMC5097135.
10. Galardini M, Koumoutsi A, Herrera-Dominguez L, Cordero Varela JA, Telzerow A, Wagih O, et al. Phe-
notype inference in an Escherichia coli strain panel. Elife. 2017; 6. Epub 2017/12/28. https://doi.org/10.
7554/eLife.31035 PMID: 29280730; PubMed Central PMCID: PMCPMC5745082.
11. Her HL, Wu YW. A pan-genome-based machine learning approach for predicting antimicrobial resis-
tance activities of the Escherichia coli strains. Bioinformatics. 2018; 34(13):i89–i95. Epub 2018/06/29.
https://doi.org/10.1093/bioinformatics/bty276 PMID: 29949970; PubMed Central PMCID:
PMCPMC6022653.
12. Nguyen M, Brettin T, Long SW, Musser JM, Olsen RJ, Olson R, et al. Developing an in silico minimum
inhibitory concentration panel test for Klebsiella pneumoniae. Sci Rep. 2018; 8(1):421. Epub 2018/01/
13. https://doi.org/10.1038/s41598-017-18972-w PMID: 29323230; PubMed Central PMCID:
PMCPMC5765115.
13. Pesesky MW, Hussain T, Wallace M, Patel S, Andleeb S, Burnham CD, et al. Evaluation of Machine
Learning and Rules-Based Approaches for Predicting Antimicrobial Resistance Profiles in Gram-nega-
tive Bacilli from Whole Genome Sequence Data. Front Microbiol. 2016; 7:1887. Epub 2016/12/15.
https://doi.org/10.3389/fmicb.2016.01887 PMID: 27965630; PubMed Central PMCID:
PMCPMC5124574.
14. Antonopoulos DA, Assaf R, Aziz RK, Brettin T, Bun C, Conrad N, et al. PATRIC as a unique resource
for studying antimicrobial resistance. Brief Bioinform. 2017. Epub 2017/10/03. https://doi.org/10.1093/
bib/bbx083 PMID: 28968762.
15. Rahman SF, Olm MR, Morowitz MJ, Banfield JF. Machine Learning Leveraging Genomes from Meta-
genomes Identifies Influential Antibiotic Resistance Genes in the Infant Gut Microbiome. mSystems.
2018; 3(1). Epub 2018/01/24. https://doi.org/10.1128/mSystems.00123-17 PMID: 29359195; PubMed
Central PMCID: PMCPMC5758725.
16. Wheeler NE, Gardner PP, Barquist L. Machine learning identifies signatures of host adaptation in the
bacterial pathogen Salmonella enterica. PLoS Genet. 2018; 14(5):e1007333. Epub 2018/05/09. https://
doi.org/10.1371/journal.pgen.1007333 PMID: 29738521.
17. Kallonen T, Brodrick HJ, Harris SR, Corander J, Brown NM, Martin V, et al. Systematic longitudinal sur-
vey of invasive Escherichia coli in England demonstrates a stable population structure only transiently
disturbed by the emergence of ST131. Genome Res. 2017. https://doi.org/10.1101/gr.216606.116
PMID: 28720578; PubMed Central PMCID: PMCPMC5538559.
Prediction of antibiotic resistance from pan-genome data
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1006258 December 14, 2018 15 / 17
18. Runcharoen C, Raven KE, Reuter S, Kallonen T, Paksanont S, Thammachote J, et al. Whole genome
sequencing of ESBL-producing Escherichia coli isolated from patients, farm waste and canals in Thai-
land. Genome Med. 2017; 9(1):81. https://doi.org/10.1186/s13073-017-0471-8 PMID: 28877757;
PubMed Central PMCID: PMCPMC5588602.
19. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using
PCR products. Proc Natl Acad Sci U S A. 2000; 97(12):6640–5. Epub 2000/06/01. https://doi.org/10.
1073/pnas.120163297 PMID: 10829079; PubMed Central PMCID: PMCPMC18686.
20. Wood DE, Salzberg SL. Kraken: ultrafast metagenomic sequence classification using exact alignments.
Genome Biol. 2014; 15(3):R46. Epub 2014/03/04. https://doi.org/10.1186/gb-2014-15-3-r46 PMID:
24580807; PubMed Central PMCID: PMCPMC4053813.
21. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs.
Genome Res. 2008; 18(5):821–9. https://doi.org/10.1101/gr.074492.107 PMID: 18349386; PubMed
Central PMCID: PMCPMC2336801.
22. Page AJ, De Silva N, Hunt M, Quail MA, Parkhill J, Harris SR, et al. Robust high-throughput prokaryote
de novo assembly and improvement pipeline for Illumina data. Microb Genom. 2016; 2(8):e000083.
https://doi.org/10.1099/mgen.0.000083 PMID: 28348874; PubMed Central PMCID:
PMCPMC5320598.
23. Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014; 30(14):2068–9.
https://doi.org/10.1093/bioinformatics/btu153 PMID: 24642063.
24. Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MT, et al. Roary: rapid large-scale pro-
karyote pan genome analysis. Bioinformatics. 2015; 31(22):3691–3. https://doi.org/10.1093/
bioinformatics/btv421 PMID: 26198102; PubMed Central PMCID: PMCPMC4817141.
25. Letunic I, Bork P. Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylo-
genetic and other trees. Nucleic Acids Res. 2016; 44(W1):W242–5. Epub 2016/04/21. https://doi.org/
10.1093/nar/gkw290 PMID: 27095192; PubMed Central PMCID: PMCPMC4987883.
26. Forde BM, Ben Zakour NL, Stanton-Cook M, Phan MD, Totsika M, Peters KM, et al. The complete
genome sequence of Escherichia coli EC958: a high quality reference sequence for the globally dissem-
inated multidrug resistant E. coli O25b:H4-ST131 clone. PLoS One. 2014; 9(8):e104400. Epub 2014/
08/16. https://doi.org/10.1371/journal.pone.0104400 PMID: 25126841; PubMed Central PMCID:
PMCPMC4134206.
27. Moradigaravand D, Boinett CJ, Martin V, Peacock SJ, Parkhill J. Recent independent emergence of
multiple multidrug-resistant Serratia marcescens clones within the United Kingdom and Ireland.
Genome Res. 2016; 26(8):1101–9. Epub 2016/07/20. https://doi.org/10.1101/gr.205245.116 PMID:
27432456; PubMed Central PMCID: PMCPMC4971767.
28. Paradis E, Claude J, Strimmer K. APE: Analyses of Phylogenetics and Evolution in R language. Bioin-
formatics. 2004; 20(2):289–90. Epub 2004/01/22. PMID: 14734327.
29. Jombart T. adegenet: a R package for the multivariate analysis of genetic markers. Bioinformatics.
2008; 24(11):1403–5. https://doi.org/10.1093/bioinformatics/btn129 PMID: 18397895.
30. Brynildsrud O, Bohlin J, Scheffer L, Eldholm V. Rapid scoring of genes in microbial pan-genome-wide
association studies with Scoary. Genome Biol. 2016; 17(1):238. https://doi.org/10.1186/s13059-016-
1108-8 PMID: 27887642; PubMed Central PMCID: PMCPMC5124306.
31. Pedregosa et al., Scikit-learn: Machine Learning in Python, JMLR, 2011, 12, pp. 2825–2830,.
32. Inouye M, Conway TC, Zobel J, Holt KE. Short read sequence typing (SRST): multi-locus sequence
types from short reads. BMC Genomics. 2012; 13:338. https://doi.org/10.1186/1471-2164-13-338
PMID: 22827703; PubMed Central PMCID: PMCPMC3460743.
33. Moon DC, Seol SY, Gurung M, Jin JS, Choi CH, Kim J, et al. Emergence of a new mutation and its accu-
mulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escheri-
chia coli isolates. Int J Antimicrob Agents. 2010; 35(1):76–9. Epub 2009/09/29. https://doi.org/10.1016/
j.ijantimicag.2009.08.003 PMID: 19781915.
34. Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis. 2005; 41 Suppl 2:S120–6. Epub
2005/06/09. https://doi.org/10.1086/428052 PMID: 15942878.
35. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifac-
eted threat. Clin Microbiol Rev. 2009; 22(4):664–89. Epub 2009/10/14. https://doi.org/10.1128/CMR.
00016-09 PMID: 19822894; PubMed Central PMCID: PMCPMC2772364.
36. Canton R, Morosini MI, de la Maza OM, de la Pedrosa EG. IRT and CMT beta-lactamases and inhibitor
resistance. Clin Microbiol Infect. 2008; 14 Suppl 1:53–62. Epub 2007/12/25. https://doi.org/10.1111/j.
1469-0691.2007.01849.x PMID: 18154528.
Prediction of antibiotic resistance from pan-genome data
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1006258 December 14, 2018 16 / 17
37. Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin
Microbiol Rev. 2014; 27(3):543–74. Epub 2014/07/02. https://doi.org/10.1128/CMR.00125-13 PMID:
24982321; PubMed Central PMCID: PMCPMC4135899.
38. Jones William, Alasoo Kaur, Fishman Dmytro, Parts Leopold, Computational biology: deep learning,
2017, https://doi.org/10.1042/ETLS20160025, Emerging Topics in Life Sciences
39. Aun E, Brauer A, Kisand V, Tenson T, Remm M. A k-mer-based method for the identification of pheno-
type-associated genomic biomarkers and predicting phenotypes of sequenced bacteria. PLoS Comput
Biol. 2018; 14(10):e1006434. Epub 2018/10/23. https://doi.org/10.1371/journal.pcbi.1006434 PMID:
30346947; PubMed Central PMCID: PMCPMC6211763.
40. Lees JA, Vehkala M, Valimaki N, Harris SR, Chewapreecha C, Croucher NJ, et al. Sequence element
enrichment analysis to determine the genetic basis of bacterial phenotypes. Nat Commun. 2016;
7:12797. Epub 2016/09/17. https://doi.org/10.1038/ncomms12797 PMID: 27633831; PubMed Central
PMCID: PMCPMC5028413.
Prediction of antibiotic resistance from pan-genome data
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1006258 December 14, 2018 17 / 17
